LETTER | The American Malaysian Chamber of Commerce (Amcham) welcomes a review of the procurement process by the Malaysian authorities especially in light of recent reports of multi-billion ringgit ‘medicine monopoly.”

US companies maintain high standards of business practices and have rigorous compliance processes that ensure conformity to national and international laws including, but not limited to, Malaysian legislation on competition and anti-corruption, the US Foreign Corrupt Practices Act and the UK Bribery Act.

Our members in the healthcare sector are encouraged by the Health Minister’s interest in examining this issue, and Amcham stands ready to work collaboratively with the relevant stakeholders to ensure that Malaysians have access to the healthcare they need.

The views expressed here are those of the author/contributor and do not necessarily represent the views of Malaysiakini.